AUTHOR

Sohini Das

All stories by Sohini Das

Gut Health Key To Prevent Chronic Illnesses
Rediff.com5 days ago

Maintaining the balance of gut microbiota is important as an imbalance, also known as...

Zydus gets China nod for kidney disease drug
Rediff.com5 days ago

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its...

Nearly one in two luxury cars sold in March quarter was Mercedes Benz
Rediff.com12 Apr 2024

Nearly one in two luxury cars sold in India in the first three months of 2024 was a...

Why Drug Prices Won't Increase This Year
Rediff.com5 Apr 2024

The government has been stringent with pricing changes. Prices of 651 essential...

Why Hospital Stays Are Getting Shorter
Rediff.com3 Apr 2024

'Every hospital now tracks length of stay closely.' 'More efficiency is brought into...

Indian pharma companies bank on 'mother brands' to boost revenue growth
Rediff.com28 Mar 2024

Indian pharma companies are focussing on flagship products or mother brands under which...

Skoda to drive in Brezza, Sonet rival in H1FY25
Rediff.com28 Feb 2024

koda Auto India is set to drive in a new car by the first half of next year to reach...

GOOD News! No Drug Price Hike In 2024
Rediff.com6 Feb 2024

For the consumer, there would be practically no impact on prices of essential medicines...

Q3 result preview: US, India to aid revenue growth for Pharma Inc
Rediff.com30 Jan 2024

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent...

'Aster DM's plan is to be among top three in India'
Rediff.com27 Jan 2024

'Now that we are a pure-play India business, many investors are open to investing.'

Fortis plans acquisitions, may opt for neutral brand name
Rediff.com22 Jan 2024

Delhi-headquartered Fortis Healthcare is open to acquisition of hospitals with over...

Domestic pharma market grew by 6.8% in 2023
Rediff.com22 Jan 2024

The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93...

From Ashok Leyland to VECV, busmakers' sales entered the fast lane in 2023
Rediff.com10 Jan 2024

The demand for buses largely remained robust in 2023, driven by the increasing need for...

'APIs are a very strategic part of Biocon's business'
Rediff.com7 Jan 2024

'There is no reason why we should break this business up.'

Trade generics growth to dent value expansion of domestic drug market
Rediff.com2 Jan 2024

Rising penetration of trade generic medicines is eating into the value growth of the...

Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod
Rediff.com28 Dec 2023

As of now, Gennova Biopharmaceuticals has launched a vaccine, Gemcovac-OM, which is...

Does India have enough vaccine reserves to combat another Covid wave?
Rediff.com27 Dec 2023

According to CoWIN data, only 73 vaccination centres are currently active in India, of...

Medica + Manipal Will Overtake Apollo
Rediff.com12 Dec 2023

Next year Medica and Manipal will merge, making the amalgamated entity the largest...

Auto industry Q2 preview: Product mix, commodity tailwinds to aid margins
Rediff.com21 Oct 2023

Automobile manufacturers are likely to report strong numbers for the September quarter...

Nirma's new clothes: The journey of detergent brand towards healthcare
Rediff.com12 Oct 2023

Nirma's tryst with the pharmaceutical space started in 2006 when it acquired the ailing...